Larimar Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Larimar Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2013 to Q3 2024.
  • Larimar Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.96M, a 7.47% increase year-over-year.
  • Larimar Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $8.31M, a 13.2% increase year-over-year.
  • Larimar Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.62M, a 15% increase from 2022.
  • Larimar Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.62M, a 20.9% increase from 2021.
  • Larimar Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.47M, a 153% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $8.31M $1.96M +$136K +7.47% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $8.17M $2.3M +$259K +12.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $7.91M $2.13M +$295K +16.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $7.62M $1.92M +$277K +16.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $7.34M $1.82M +$154K +9.24% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $7.18M $2.04M +$367K +21.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $6.82M $1.83M +$198K +12.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $6.62M $1.64M +$162K +10.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $6.46M $1.67M +$204K +13.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $6.25M $1.68M +$325K +24.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $5.93M $1.64M +$455K +38.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $5.47M $1.48M +$470K +46.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $5M $1.46M +$1.09M +295% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $3.91M $1.35M +$598K +79.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $3.31M $1.18M +$1.15M +3969% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $2.16M $1.01M +$3.02M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 -$861K $370K +$338K +1056% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$1.2M $752K +$719K +2179% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$1.92M $29K -$2.05M -98.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $129K -$2.01M -$4.3M -188% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 $4.43M $32K -$2.17M -98.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $6.6M $33K -$2.64M -98.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $9.24M $2.08M -$390K -15.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $9.63M $2.29M +$188K +8.94% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 $9.44M $2.2M +$104K +4.96% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $9.34M $2.67M +$569K +27.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $8.77M $2.47M +$465K +23.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $8.3M $2.1M +$95K +4.73% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-05
Q3 2017 $8.21M $2.1M -$220K -9.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $8.43M $2.1M -$752K -26.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $9.18M $2M -$755K -27.4% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $9.93M $2.01M -$738K -26.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-14
Q3 2016 $10.7M $2.32M -$525K -18.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $11.2M $2.85M +$915K +47.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $10.3M $2.76M +$1.7M +161% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $8.58M $2.75M +$2.1M +327% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 $6.48M $2.84M +$2.38M +510% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $4.11M $1.94M +$1.67M +624% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $2.43M $1.06M +$881K +501% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $1.55M $643K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 $466K +$367K +371% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $268K +$165K +160% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $176K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q3 2013 $99K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $103K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.